SPCs: Paris court confirms its interpretation of CJEU ‘Royalty Pharma’ test
The Paris Court of Appeal has rejected a patent holder’s interpretation of EU case law that concerns criteria for obtaining supplementary protection certificates (SPCs) for innovations in medicine.
